The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Oteseconazole Capsules were found to be safe and more effective than fluconazole
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Subscribe To Our Newsletter & Stay Updated
